Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006214 · ClinicalTrials.gov registry record · Phase 2

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

A Phase 2 study of Prostate Cancer, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
Phase 2
Development phase
63
Enrollment target
20
Study locations

NCT00006214 is a Phase 2 study of Prostate Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 63 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006214, a Phase 2 study of Prostate Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
Phase 2
Development phase
63 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs such as flutamide to try to prevent the development of cancer. Flutamide may be effective in the prevention of prostate cancer. PURPOSE: Randomized clinical trial to study the effectiveness of flutamide in preventing prostate cancer in patients who have neoplasia of the prostate.

Conditions Studied

Prostate Cancer

Interventions

  • OTHER placebo
  • DRUG flutamide

Study Locations (20)

Minnesota

  • CCOP - Duluth - Duluth
  • Mayo Clinic Cancer Center - Rochester
  • CentraCare Clinic - Saint Cloud
  • CCOP - Metro-Minnesota - Saint Louis Park

Iowa

  • CCOP - Cedar Rapids Oncology Project - Cedar Rapids
  • CCOP - Iowa Oncology Research Association - Des Moines
  • Siouxland Hematology-Oncology - Sioux City

North Dakota

  • Quain & Ramstad Clinic, P.C. - Bismarck
  • CCOP - Merit Care Hospital - Fargo
  • Altru Health Systems - Grand Forks

Illinois

  • CCOP - Illinois Oncology Research Association - Peoria
  • CCOP - Carle Cancer Center - Urbana

Pennsylvania

  • CCOP - Geisinger Clinical and Medical Center - Danville
  • Penn State Geisinger Medical Center - Danville

Arizona

  • CCOP - Scottsdale Oncology Program - Scottsdale

Kansas

  • CCOP - Wichita - Wichita

Louisiana

  • CCOP - Ochsner - New Orleans

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2000-08
Est. Completion 2006-07
Phase Phase 2

Sponsor

Alliance for Clinical Trials in Oncology

446 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00006214

The ClinicalTrials.gov registry entry for NCT00006214 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00006214 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Minnesota, Iowa, North Dakota.

Frequently Asked Questions

What is clinical trial NCT00006214 about?

NCT00006214 is a clinical study titled "Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate". RATIONALE: Chemoprevention therapy is the use of certain drugs such as flutamide to try to prevent the development of cancer. Flutamide may be effective in the prevention of prostate cancer. PURPOSE: Randomized clinical trial to study the effectiveness of flutamide in preventing prostate cancer in ...

What is the current status of trial NCT00006214?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2000-08. Estimated completion is 2006-07.

What conditions does trial NCT00006214 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT00006214?

The interventions under investigation include: placebo (OTHER), flutamide (DRUG).

Who is sponsoring clinical trial NCT00006214?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00006214 being conducted?

This trial has 20 study locations across Arizona, Illinois, Iowa, Kansas, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.